2nd Targeted Protein Degradation

As the previously untapped drug discovery opportunity promised within the proteome becomes a reality and “undruggable” targets are finally being reached, the field of targeted protein degradation is truly changing the face of small molecule drug discovery. In the pursuit to demonstrate safe and effective clinical results, it's clear that a set of unique development challenges must be overcome for these novel therapeutics to achieve their seemingly limitless potential.

With 50+ speakers, 40+ late-breaking case studies, 3 dedicated streams, 6 technical deep-dives & 300+ attendees, TPD 2019 is the most comprehensive and definitive guide for large pharma, innovative biotech and leading academic researchers to capitalize on this emerging therapeutic class and make targeted protein degradation a blockbuster therapeutic approach that improves patient outcomes.